Skip to main content

Table 2 Distribution of response types among patients treated with cis-platinum

From: Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Response

Number

Evidence of progression

Time to progression Median (months)

Number deceased

Complete

9

9

17

6

Partial

7

7

8

6

Stable

3

3

3

3

Progressive

1

1

1

1